508 related articles for article (PubMed ID: 29503329)
1. Neuroimaging in Parkinsonian Disorders.
Tripathi M; Kumar A; Bal C
Neurol India; 2018; 66(Supplement):S68-S78. PubMed ID: 29503329
[TBL] [Abstract][Full Text] [Related]
2. Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.
Saeed U; Lang AE; Masellis M
Front Neurol; 2020; 11():572976. PubMed ID: 33178113
[TBL] [Abstract][Full Text] [Related]
3. What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective.
Thobois S; Prange S; Scheiber C; Broussolle E
Parkinsonism Relat Disord; 2019 Feb; 59():93-100. PubMed ID: 30181086
[TBL] [Abstract][Full Text] [Related]
4. The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice.
Dąbrowska M; Schinwelski M; Sitek EJ; Muraszko-Klaudel A; Brockhuis B; Jamrozik Z; Sławek J
Neurol Neurochir Pol; 2015; 49(6):421-31. PubMed ID: 26652877
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility and research frontiers of neuroimaging in movement disorders.
Nobili F; Westman E; Kogan RV; Pereira JB; Massa F; Grazzini M; Meles SK; Leenders KL
Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):372-385. PubMed ID: 28849633
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging.
Arnaldi D; Morbelli S; Morrone E; Campus C; Nobili F
Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):55-67. PubMed ID: 22460160
[TBL] [Abstract][Full Text] [Related]
7. Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.
Buchert R; Buhmann C; Apostolova I; Meyer PT; Gallinat J
Dtsch Arztebl Int; 2019 Nov; 116(44):747-754. PubMed ID: 31774054
[TBL] [Abstract][Full Text] [Related]
8. Brain TRODAT-SPECT Versus MRI Morphometry in Distinguishing Early Mild Parkinson's Disease from Other Extrapyramidal Syndromes.
Hossein-Tehrani MR; Ghaedian T; Hooshmandi E; Kalhor L; Foroughi AA; Ostovan VR
J Neuroimaging; 2020 Sep; 30(5):683-689. PubMed ID: 32557946
[TBL] [Abstract][Full Text] [Related]
9. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
[TBL] [Abstract][Full Text] [Related]
10. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.
Cummings JL; Henchcliffe C; Schaier S; Simuni T; Waxman A; Kemp P
Brain; 2011 Nov; 134(Pt 11):3146-66. PubMed ID: 21810889
[TBL] [Abstract][Full Text] [Related]
11. Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?
Shimizu S; Kanetaka H; Hirao K; Fukasawa R; Namioka N; Hatanaka H; Hirose D; Umahara T; Sakurai H; Hanyu H
Geriatr Gerontol Int; 2017 May; 17(5):819-824. PubMed ID: 27138074
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-TRODAT-1 SPECT/CT imaging as a complementary biomarker in the diagnosis of parkinsonian syndromes.
Mittal BR; Sood A; Shukla J; Vatsa R; Bhusari P; Shree R; Mehta S; Goyal M; Modi M
Nucl Med Commun; 2018 Apr; 39(4):312-318. PubMed ID: 29381583
[TBL] [Abstract][Full Text] [Related]
13. [Not Available].
Prange S; Hermier M; Danaila T; Laurencin C; Thobois S
Presse Med; 2017 Mar; 46(2 Pt 1):202-209. PubMed ID: 28040345
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes.
Vlaar AM; van Kroonenburgh MJ; Kessels AG; Weber WE
BMC Neurol; 2007 Sep; 7():27. PubMed ID: 17764571
[TBL] [Abstract][Full Text] [Related]
15. [Study of the pre and post-synaptic dopaminergic system by DaTSCAN/IBZM SPECT in the differential diagnosis of parkinsonism in 75 patients].
Vaamonde J; Ibáñez R; García AM; Poblete V
Neurologia; 2004; 19(6):292-300. PubMed ID: 15199417
[TBL] [Abstract][Full Text] [Related]
16. Role of Neuroimaging on Differentiation of Parkinson's Disease and Its Related Diseases.
Ogawa T; Fujii S; Kuya K; Kitao SI; Shinohara Y; Ishibashi M; Tanabe Y
Yonago Acta Med; 2018 Sep; 61(3):145-155. PubMed ID: 30275744
[TBL] [Abstract][Full Text] [Related]
17. [Functional neuroimaging in the diagnosis of patients with Parkinsonism: Update and recommendations for clinical use].
Arbizu J; Luquin MR; Abella J; de la Fuente-Fernández R; Fernandez-Torrón R; García-Solís D; Garrastachu P; Jiménez-Hoyuela JM; Llaneza M; Lomeña F; Lorenzo-Bosquet C; Martí MJ; Martinez-Castrillo JC; Mir P; Mitjavila M; Ruiz-Martínez J; Vela L
Rev Esp Med Nucl Imagen Mol; 2014; 33(4):215-26. PubMed ID: 24731551
[TBL] [Abstract][Full Text] [Related]
18. Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study.
Nicastro N; Burkhard PR; Garibotto V
J Neurol Sci; 2018 Feb; 385():17-21. PubMed ID: 29406901
[TBL] [Abstract][Full Text] [Related]
19. Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism.
Brooks DJ
Neurotherapeutics; 2021 Apr; 18(2):753-771. PubMed ID: 33432494
[TBL] [Abstract][Full Text] [Related]
20. Imaging neurodegeneration in Parkinson's disease.
Pavese N; Brooks DJ
Biochim Biophys Acta; 2009 Jul; 1792(7):722-9. PubMed ID: 18992326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
